Gene: GPR162
Official Full Name: G protein-coupled receptor 162provided by HGNC
Gene Summary: This gene was identified upon genomic analysis of a gene-dense region at human chromosome 12p13. It appears to be mainly expressed in the brain; however, its function is not known. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27737 | GPR162 Knockout cell line (HCT 116) | Human | GPR162 | 1:2~1:4 | Negative | Online Inquiry |
KO27738 | GPR162 Knockout cell line (HEK293) | Human | GPR162 | 1:3~1:6 | Negative | Online Inquiry |
KO27739 | GPR162 Knockout cell line (A549) | Human | GPR162 | 1:3~1:4 | Negative | Online Inquiry |
GPR162 Gene Knockout Cell Lines are genetically modified cell lines engineered to lack the expression of the GPR162 gene, which encodes a member of the G protein-coupled receptor (GPCR) family. These cell lines serve as invaluable tools for elucidating the role of GPR162 in various biological systems, particularly in the context of neurobiology and metabolic regulation.
The key function of GPR162 is its involvement in signal transduction pathways that influence cellular responses to physiological stimuli. By utilizing GPR162 Gene Knockout Cell Lines, researchers can investigate the molecular mechanisms underlying GPR162-mediated signaling and its effects on cellular processes such as inflammation, differentiation, and apoptosis. This enables a deeper understanding of its contribution to conditions like obesity, diabetes, and neurological disorders.
The significance of GPR162 Gene Knockout Cell Lines extends to both fundamental research and clinical applications. They present an opportunity to identify potential therapeutic targets for drug development, especially given the critical role of GPCRs in pharmacology. In pharmaceutical research, these cell lines can facilitate high-throughput screening of small compounds, leading to the discovery of novel inhibitors or activators of GPR162-related pathways.
When compared to existing alternatives, GPR162 Gene Knockout Cell Lines are characterized by their precise gene editing via CRISPR-Cas9 technology, resulting in robust and reproducible loss of gene function. This precision allows for more reliable experimental design and interpretation of results, ultimately enabling researchers to achieve meaningful outcomes.
Researchers and clinicians will find great value in GPR162 Gene Knockout Cell Lines, as they provide a unique foundation for advancing knowledge in GPCR biology while paving the way for developing innovative therapeutic strategies. With a strong commitment to genetic engineering and cellular biology, our company specializes in delivering high-quality biological products that empower the scientific community to explore and unlock the complexities of gene function and regulation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.